Colon cancer: the 2023 Korean clinical practice guidelines for diagnosis and treatment
- PMID: 38712437
- PMCID: PMC11082542
- DOI: 10.3393/ac.2024.00059.0008
Colon cancer: the 2023 Korean clinical practice guidelines for diagnosis and treatment
Abstract
Colorectal cancer is the third most common cancer in Korea and the third leading cause of death from cancer. Treatment outcomes for colon cancer are steadily improving due to national health screening programs with advances in diagnostic methods, surgical techniques, and therapeutic agents.. The Korea Colon Cancer Multidisciplinary (KCCM) Committee intends to provide professionals who treat colon cancer with the most up-to-date, evidence-based practice guidelines to improve outcomes and help them make decisions that reflect their patients' values and preferences. These guidelines have been established by consensus reached by the KCCM Guideline Committee based on a systematic literature review and evidence synthesis and by considering the national health insurance system in real clinical practice settings. Each recommendation is presented with a recommendation strength and level of evidence based on the consensus of the committee.
Keywords: Colonic neoplasms; Diagnosis; Genetics; Humans; Therapy.
Conflict of interest statement
Je-Ho Jang is an Editorial Board member of
References
-
- National Cancer Information Center . National Cancer Information Center (Korea); c2023. Cancer in statistics [Internet] [cited 2023 Oct 8]. Korean. Available from: https://www.cancer.go.kr/
-
- Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–75. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
